Combination therapy shows promising results in treating stage 3 melanoma
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of ...
Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of ...
In recent years, machine learning models have become increasingly popular for risk assessment of chemical compounds. However, they are often ...
In this interview, NewsMedical talks to Dr. James Mencel’s Guidance about Scaling Up API Processes. Could you please introduce yourself ...
A review article published in the journal Current Research in Food Science describes the anti-obesity modes of action of bioactive ...
The world is approaching a low-fertility future. Although by 2100 more than 97% of countries and territories will have fertility ...
Researchers from the London School of Hygiene & Tropical Medicine (LSHTM) have been awarded £2m funding through the UK Research ...
The death rate for patients with functional, nonepileptic seizures is higher than expected, with a rate comparable to epilepsy and ...
In this new episode of omg OMx, Kate Stumpo speaks to Bruker's Mike Greig about the incredible potential of mass ...
Researchers at the University of Michigan Health Rogel Cancer Center have identified a mechanism that causes severe gastrointestinal problems with ...
The University of Texas MD Anderson Cancer Center and Rigel Pharmaceuticals, Inc. today announced a multi-year strategic development collaboration to ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net